Loading...
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Hanna, C. R. O'Cathail, S. M. Graham, J. S. Saunders, Mark P Samuel, L. Harrison, M. Devlin, L. Edwards, J. Gaya, D. R. Kelly, C. A.
Hanna, C. R.
O'Cathail, S. M.
Graham, J. S.
Saunders, Mark P
Samuel, L.
Harrison, M.
Devlin, L.
Edwards, J.
Gaya, D. R.
Kelly, C. A.
Citations
Altmetric:
Abstract
Description
Date
2021
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 565.75 KB
Keywords
Type
Other
Citation
Hanna CR, O’Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, et al. Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) Vol. 16, Radiation Oncology. Springer Science and Business Media LLC; 2021.